Cited by 67Amyotrophic Lateral Sclerosis ResearchAmyloidosis: Diagnosis, Treatment, OutcomesNutrition and Health in Aging

Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans

Open access
Mariosa, Daniela, Beard, John D., Umbach, David M., Bellocco, Rino, Keller, Jean, Peters, Tracy L., Allen, Kelli D., Ye, Weimin +4 more·2017·American Journal of Epidemiology

Abstract

Amyotrophic lateral sclerosis (ALS) may be associated with low body mass index (BMI) at the time of diagnosis. However, the role of premorbid BMI in the development of ALS and survival after diagnosis remains unclear. In 2005-2010, we interviewed 467 patients with ALS from the US National Registry of Veterans with ALS and 975 frequency-matched veteran controls. In this sample, we evaluated the association of BMI and BMI change at different ages with ALS risk using unconditional logistic models and with survival after ALS diagnosis using Cox proportional hazards models. After adjustment for confounders, compared with a moderate increase in BMI between ages 25 and 40 years, stable or decreasing BMI was positively associated with ALS risk (odds ratio (OR) = 1.61, 95% confidence interval (CI): 1.20, 2.16). A 1-unit increase in BMI at age 40 years (OR = 0.95, 95% CI: 0.91, 0.98) but not at age 25 years (OR = 0.99, 95% CI: 0.95, 1.03) was inversely associated with ALS. These associations were similar for bulbar and spinal ALS but stronger for those with a delay of less than 1 year between symptom onset and diagnosis. We found no association between prediagnosis BMI and survival. A decreasing BMI from early to middle age and a low BMI in middle age may be positively associated with ALS risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/aje/kww140

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344(22):1688-1700.
  2. Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013;9(11):617-628.
  3. Turner MR, Hardiman O, Benatar M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12(3):310-322.
  4. Desport JC, Preux PM, Magy L, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74(3):328-334.
  5. Krentz AJ, Williams AC, Nattrass M. Abnormal regulation of carbohydrate metabolism in motor neurone disease. Diabetes Res. 1991;16(2):93-99.
  6. Murai A, Miyahara T, Tanaka T, et al. Abnormalities of lipoprotein and carbohydrate metabolism in degenerative diseases of the nervous system-motor neuron disease and spinocerebellar degeneration. Tohoku J Exp Med. 1983; 139(4):365-376.
  7. Lindauer E, Dupuis L, Müller HP, et al. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One. 2013;8(6):e67783.
  8. Ngo ST, Steyn FJ, McCombe PA. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis. J Neurol Sci. 2014;340(1-2):5-12.
  9. Dorst J, Kühnlein P, Hendrich C, et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol. 2011; 258(4):613-617.
  10. Dupuis L, Pradat PF, Ludolph AC, et al. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1): 75-82.
  11. Desport JC, Preux PM, Truong TC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059-1063.
  12. Shimizu T, Nagaoka U, Nakayama Y, et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph Lateral Scler. 2012;13(4):363-366.
  13. Gallo V, Wark PA, Jenab M, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829-838.
  14. O'Reilly ÉJ, Wang H, Weisskopf MG, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14(3):205-211.
  15. Logroscino G. The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ Health Perspect. 2005;113(9):1234-1238.
  16. Schmidt S, Allen KD, Loiacono VT, et al. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA Study. Rationale, study design and demographic characteristics. Neuroepidemiology. 2008;30(3):191-204.
  17. Allen KD, Kasarskis EJ, Bedlack RS, et al. The National Registry of Veterans with Amyotrophic Lateral Sclerosis. Neuroepidemiology. 2008;30(3):180-190.
  18. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
  19. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854: 1-452.
  20. Cetin H, Rath J, Füzi J, et al. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course. Neuroepidemiology. 2015;44(1):6-15.
  21. Ingre C, Roos PM, Piehl F, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7: 181-193.
  22. Dupuis L, Oudart H, René F, et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA. 2004;101(30):11159-11164.
  23. Wolf J, Safer A, Wöhrle JC, et al. Factors predicting one-year mortality in amyotrophic lateral sclerosis patients-data from a population-based registry. BMC Neurol. 2014;14:197.
  24. Marin B, Desport JC, Kajeu P, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628-634.
  25. Traxinger K, Kelly C, Johnson BA, et al. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997-2011. Neurol Clin Pract. 2013;3(4): 313-320.
  26. Kim SM, Kim H, Kim JE, et al. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS One. 2011;6(3):e17985.
  27. Stallings NR, Puttaparthi K, Dowling KJ, et al. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS One. 2013;8(8):e71793.
  28. Stone S, Abkevich V, Russell DL, et al. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet. 2006;15(18):2709-2720.
  29. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.
  30. Wang T, Jiang X, Chen G, et al. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways. Neurobiol Aging. 2015;36(1): 527-535.
  31. Ahmed RM, Mioshi E, Caga J, et al. Body mass index delineates ALS from FTD: implications for metabolic health. J Neurol. 2014;261(9):1774-1780.
  32. Guerreiro R, Bras J, Hardy J. SnapShot: genetics of ALS and FTD. Cell. 2015;160(4):798.e791.
  33. Walsh MJ, Cooper-Knock J, Dodd JE, et al. Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art. Neuropathol Appl Neurobiol. 2015;41(2):109-134.
  34. Chew J, Gendron TF, Prudencio M, et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348(6239):1151-1154.
  35. Eisen A, Kiernan M, Mitsumoto H, et al. Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry. 2014;85(11):1232-1238.
  36. Rafiq MK, Lee E, Bradburn M, et al. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: insights from the olesoxime clinical trial. Amyotroph Lateral Scler Frontotemporal Degener. 2015; 16(7-8):478-484.
  37. Ngo ST, Steyn FJ. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis. Cell Regen (Lond). 2015;4(1):5.
  38. Grabner M. BMI trends, socioeconomic status, and the choice of dataset. Obes Facts. 2012;5(1):112-126.
  39. Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015;37(1):55-70.
  40. Pupillo E, Messina P, Giussani G, et al. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study. Ann Neurol. 2014;75(5):708-716.

Cited by

Sorted by citations

Authors
Mariosa, D., Beard, J. D., Umbach, D. M., Bellocco, R., Keller, J., Peters, T. L., Allen, K. D., Ye, W., Sandler, D. P., Schmidt, S., Fang, F., & Kamel, F.
Affiliations
National Institute of Environmental Health Sciences (US)
Corresponding author
Kamel, Freya
Venue
American Journal of Epidemiology
Published
2017-02-02
Volume
185
Issue
5
Pages
362-371
ISSN
  • 0002-9262 (ISSN-L)
  • 1476-6256
OpenAlex
W2585081838
Cited by
67
References
2
Citations by year
2026: 4 · 2025: 8 · 2024: 8 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 11 · 2018: 4 · 2017: 1
FWCI
4.01
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • American Journal of Epidemiology (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • UNC Libraries
Funders
  • National Institutes of Health (Z01-ES049005)
  • National Institute of Environmental Health Sciences (R01-ES13244)
  • Amyotrophic Lateral Sclerosis Association (1230)
  • Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (T42OH00867302)
  • Swedish Research Council
  • Swedish Research Council for Health, Working Life and Welfare
  • Swedish Society for Medical Research
  • Karolinska Institutet
  • U.S. Department of Veterans Affairs (CSP 500A)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
amyotrophic lateral sclerosis, body mass index, ALS risk, survival after diagnosis, military veterans, bulbar ALS, National ALS Registry
MeSH terms
Adult, Amyotrophic Lateral Sclerosis, Female, Humans, Male, Middle Aged, Registries, United States, Weight Loss, Body Mass Index, Logistic Models, Proportional Hazards Models, Survival Analysis, Case-Control Studies, Sex Distribution, Veterans Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review